SKYEPHARMA

SkyePharma is a speciality drug delivery company with a proven range of oral and inhalation technologies. SkyePharma strives to deliver a clinical benefit for patients by using its multiple delivery technologies to create enhanced versions of existing pharmaceutical products as well as products incorporating new chemical entities. Combining established pre-clinical, clinical and regulatory expertise with the capability to formulate and manufacture drugs, both for clinical studies and commercial sale, SkyePharma identifies and develops potential new therapeutic products for out-licensing as well as working with partners to develop their concepts through to marketable products.
SKYEPHARMA
Social Links:
Industry:
Biotechnology Health Care Manufacturing Pharmaceutical
Founded:
1996-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.skyepharma.com
Total Employee:
101+
Status:
Active
Contact:
+442078810524
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Anaxomics Biotech SL
Anaxomics is a global leader in Drug Discovery, Predictive Safety and Drug Reprofiling by using the newest Systems Biology technologies.
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.skyepharma.com Semrush global rank: 3.84 M Semrush visits lastest month: 3.43 K
- Host name: s4.gsi-network.com
- IP address: 54.38.29.88
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris

More informations about "SkyePharma"
Skyepharma leadership team - Executive commitee
Skyepharma is managed by an executive committee : the President, the CFO, the Quality Director, the HR Director and the Development & Production Director. <style>.wpb_animate_when_almost_visible { opacity: 1; }</style>See details»
Skyepharma fully integrated CDMO for complex oral solid forms
Skyepharma is an expert CDMO specialized in formulating, developing and producing complex oral dosage forms, with complex and tailor-made modified release profiles. We offer a full โฆSee details»
Fully integrated french CDMO - classic and complex โฆ
In 2016, Skyepharma became the oral business Unit of the Vectura Group of Companies (www.vectura.com) and transformed into a fully integrated french CDMO [see our History]. In June 2021, Skyepharma becomes a newly โฆSee details»
SkyePharma - Crunchbase Company Profile & Funding
SkyePharma is a speciality drug delivery company with a proven range of oral and inhalation technologies. SkyePharma strives to deliver a clinical benefit for patients by using its multiple โฆSee details»
Skyepharma - LinkedIn
Skyepharma | 10,553 followers on LinkedIn. Expert and agile fully integrated CDMO - specializing in classic and complex oral solid forms. | Through many years of involvement and achievements in ...See details»
Skyepharma 2025 Company Profile: Valuation, Funding โฆ
Skyepharma General Information Description. Developer of pharmaceutical products intended for the biotech and consumer health industries. The company specializes in formulating, developing and producing complex oral dosage โฆSee details»
SKYEPHARMA - PharmaSource
With over 25 years of experience, Skyepharma is renowned for its expertise in the formulation, development, and production of complex, modified-release oral solid dosage forms. The โฆSee details»
Skyepharma Identity in Facts and Figures
Dec 3, 2020 Skyepharma has steadily increased its manufacturing and logistics capabilities over recent years. Available annual production capacities have now reached two billion tablets, 300 million capsules, 30 million blisters, six million โฆSee details»
SkyePharma - Contacts, Employees, Board Members, Advisors
SkyePharma is a speciality drug delivery company with a range of oral and inhalation technologies. New. Resources. ... Experience the new Crunchbase, powered by AI . โฆSee details»
Skyepharma - mai-cdmo.com
Skyepharma EXPERT AND INNOVATIVE CDMO COMPLEX ORAL SOLIDS: Fully integrated french CDMO Skyepharma is a key player in drug development and delivery of oral โฆSee details»
Skyepharma Company Profile - Office Locations, Competitors
Skyepharma is a drug delivery company developing oral and inhalation products. Its proprietary drug delivery technologies enable the development of new formulations of existing products as โฆSee details»
Skyepharma CDMO history & experience in the pharmaceutical โฆ
Skyepharma develops its business by acquiring several companies: โ The American company Depotech (San Diego), specialized in the development of sustained-release injectables, which โฆSee details»
Skyepharma Information - RocketReach
Through many years of involvement and achievements in the pharmaceutical industry, Skyepharmaโs development and manufacturing facility is eminently specialized in Complex โฆSee details»
Skyepharma
Skyepharma is an expert CDMO specialized in formulating, developing and producing complex oral dosage forms, with complex and tailor-made modified release profiles. Our scientific โฆSee details»
SkyePharma AG, Basle, Switzerland - North Data
SkyePharma AG, Basle, Switzerland, Schweizer Handelsregister CHE-106.791.435: Network, Financial information. ... product mediation, organization and monitoring of clinical trials and โฆSee details»
Skyepharma Production - ONdrugDelivery
Skyepharma is a CDMO that specialises in the manufacture of traditional and advanced solid dosage forms, including single-layer tablets, multi-layer tablets, hard gel capsules, tab-in-tab, โฆSee details»
SKYEPHARMA - PharmaSource
Nov 27, 2023 Skyepharma is a France-based CDMO expert in the formulation and manufacturing of complex oral solids (controlled release, multilayer, oncology & HPAPI, โฆSee details»
CENTER OF EXCELLENCE IN ORAL SOLID FORMS
Skyepharmaโstechnology uses an approach similar to multilayer tableting. A combination of layers modulates the release rate of the active ingredients and flavouring agents when the gum is โฆSee details»
MaaT Pharma and Skyepharma Have Entered a Partnership to โฆ
Lyon and Saint-Quentin-Fallavier, France, February, 8 2022 โ 6:00pm CET โ MaaT Pharma (EURONEXT: MAAT โ the โCompanyโ), a French clinical-stage biotech (Phase 3) and a โฆSee details»
Corporate Social Responsibility (CSR) (RSE) - Skyepharma
Corporate Social Responsibility (CSR) (RSE) Our CSR approach reflects our dedication to ethical business practices, environmental responsibility, and a positive societal impact. CSR โฆSee details»